Adrian Lison

Adrian Lison

Auto-generated profile, based on publicly available information

Adrian Lison

Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 June 2021 in PLOS ONE
Verified
Journal Article
Open access
PDF file
NBNicolas Banholzer
Nicolas Banholzer
EWEva van Weenen
Eva van Weenen
ALAdrian Lison
Adrian Lison
ACAlberto Cenedese
Alberto Cenedese
ASArne Seeliger
Arne Seeliger
WVWerner Vach
Werner Vach
The novel coronavirus (SARS-CoV-2) has rapidly developed into a global epidemic. To control its spread, countries have implemented non-pharmaceutical interventions (NPIs), such as school closures, bans of small gatherings, or even stay-at-home orders. Here we study the effectiveness of seven NPIs in reducing the number of new infections, which was inferred from the reported cases of COVID-19 using a semi-mechanistic Bayesian hierarchical model. Based on data from the first epidemic wave ofn= 20 countries (i.e., the United States, Canada, Australia, the EU-15 countries, Norway, and Switzerland), we estimate the relative reduction in the number of new infections attributed to each NPI. Among the NPIs considered, bans of large gatherings were most effective, followed by venue and school closures, whereas stay-at-home orders and work-from-home orders were least effective. With this retrospective cross-country analysis, we provide estimates regarding the effectiveness of different NPIs during the first epidemic wave.

28 October 2024 in PLOS Computational Biology
Verified
Journal Article
Open access
PDF file
KCKelly Charniga
Kelly Charniga
SPSang Woo Park
Sang Woo Park
AAAndrei R Akhmetzhanov
Andrei R Akhmetzhanov
ACAnne Cori
Anne Cori
JDJonathan Dushoff
Jonathan Dushoff
SASam Abbott
Sam Abbott
Epidemiological delays are key quantities that inform public health policy and clinical practice. They are used as inputs for mathematical and statistical models, which in turn can guide control strategies. In recent work, we found that censoring, right truncation, and dynamical bias were rarely addressed correctly when estimating delays and that these biases were large enough to have knock-on impacts across a large number of use cases. Here, we formulate a checklist of best practices for estimating and reporting epidemiological delays. We also provide a flowchart to guide practitioners based on their data. Our examples are focused on the incubation period and serial interval due to their importance in outbreak response and modeling, but our recommendations are applicable to other delays. The recommendations, which are based on the literature and our experience estimating epidemiological delay distributions during outbreak responses, can help improve the robustness and utility of reported estimates and provide guidance for the evaluation of estimates for downstream use in transmission models or other analyses.

1 September 2020
Verified
Dataset
Closed access
SASam Abbott
Sam Abbott
JHJoel Hellewell
Joel Hellewell
KSKatharine Sherratt
Katharine Sherratt
KGKatelyn Gostic
Katelyn Gostic
JHJoe Hickson
Joe Hickson
SFSebastian Funk
Sebastian Funk

16 April 2024 in PLOS Computational Biology
Verified
Journal Article
Open access
PDF file
ALAdrian Lison
Adrian Lison
SASam Abbott
Sam Abbott
JHJana Huisman
Jana Huisman
TSTanja Stadler
Tanja Stadler
The time-varying effective reproduction number Rt is a widely used indicator of transmission dynamics during infectious disease outbreaks. Timely estimates of Rt can be obtained from reported cases counted by their date of symptom onset, which is generally closer to the time of infection than the date of report. Case counts by date of symptom onset are typically obtained from line list data, however these data can have missing information and are subject to right truncation. Previous methods have addressed these problems independently by first imputing missing onset dates, then adjusting truncated case counts, and finally estimating the effective reproduction number. This stepwise approach makes it difficult to propagate uncertainty and can introduce subtle biases during real-time estimation due to the continued impact of assumptions made in previous steps. In this work, we integrate imputation, truncation adjustment, and Rt estimation into a single generative Bayesian model, allowing direct joint inference of case counts and Rt from line list data with missing symptom onset dates. We then use this framework to compare the performance of nowcasting approaches with different stepwise and generative components on synthetic line list data for multiple outbreak scenarios and across different epidemic phases. We find that under reporting delays realistic for hospitalization data (50% of reports delayed by more than a week), intermediate smoothing, as is common practice in stepwise approaches, can bias nowcasts of case counts and Rt, which is avoided in a joint generative approach due to shared regularization of all model components. On incomplete line list data, a fully generative approach enables the quantification of uncertainty due to missing onset dates without the need for an initial multiple imputation step. In a real-world comparison using hospitalization line list data from the COVID-19 pandemic in Switzerland, we observe the same qualitative differences between approaches. The generative modeling components developed in this work have been integrated and further extended in the R package epinowcast, providing a flexible and interpretable tool for real-time surveillance.

24 September 2022 in European Journal of Epidemiology
Verified
Journal Article
Open access
PDF file
NBNicolas Banholzer
Nicolas Banholzer
ALAdrian Lison
Adrian Lison
DÖDennis Özcelik
Dennis Özcelik
TSTanja Stadler
Tanja Stadler
SFStefan Feuerriegel
Stefan Feuerriegel
WVWerner Vach
Werner Vach
Non-pharmaceutical interventions, such as school closures and stay-at-home orders, have been implemented around the world to control the spread of SARS-CoV-2. Their effectiveness in improving health-related outcomes has been the subject of numerous empirical studies. However, these studies show fairly large variation among methodologies in use, reflecting the absence of an established methodological framework. On the one hand, variation in methodologies may be desirable to assess the robustness of results; on the other hand, a lack of common standards can impede comparability among studies. To establish a comprehensive overview over the methodologies in use, we conducted a systematic review of studies assessing the effectiveness of non-pharmaceutical interventions between January 1, 2020 and January 12, 2021 (n = 248). We identified substantial variation in methodologies with respect to study setting, outcome, intervention, methodological approach, and effectiveness assessment. On this basis, we point to shortcomings of existing studies and make recommendations for the design of future studies.

10 March 2022 in Eurosurveillance
Verified
Journal Article
Open access
ALAdrian Lison
Adrian Lison
JPJoel Persson
Joel Persson
NBNicolas Banholzer
Nicolas Banholzer
SFStefan Feuerriegel
Stefan Feuerriegel
Introduction: Human mobility was considerably reduced during the COVID-19 pandemic. To support disease surveillance, it is important to understand the effect of mobility on transmission.Aim: We compared the role of mobility during the first and second COVID-19 wave in Switzerland by studying the link between daily travel distances and the effective reproduction number (Rt) of SARS-CoV-2.Methods: We used aggregated mobile phone data from a representative panel survey of the Swiss population to measure human mobility. We estimated the effects of reductions in daily travel distance onRtvia a regression model. We compared mobility effects between the first (2 March–7 April 2020) and second wave (1 October–10 December 2020).Results: Daily travel distances decreased by 73% in the first and by 44% in the second wave (relative to February 2020). For a 1% reduction in average daily travel distance,Rtwas estimated to decline by 0.73% (95% credible interval (CrI): 0.34–1.03) in the first wave and by 1.04% (95% CrI: 0.66–1.42) in the second wave. The estimated mobility effects were similar in both waves for all modes of transport, travel purposes and sociodemographic subgroups but differed for movement radius.Conclusion: Mobility was associated with SARS-CoV-2Rtduring the first two epidemic waves in Switzerland. The relative effect of mobility was similar in both waves, but smaller mobility reductions in the second wave corresponded to smaller overall reductions inRt. Mobility data from mobile phones have a continued potential to support real-time surveillance of COVID-19.